カテゴリー： QYResearch, 世界, 医療/バイオ

世界の薬物溶出性ミクロスフェア市場インサイト及び予測（容量2ml、容量4ml、その他）

◆英語タイトル：Global Drug Elutable Microspheres Market Insights, Forecast to 2028
	◆商品コード：QY22JL3499 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：90 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、薬物溶出性ミクロスフェアのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬物溶出性ミクロスフェアの世界市場のxxx％を占める「容量2ml」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
薬物溶出性ミクロスフェアの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの薬物溶出性ミクロスフェア市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

薬物溶出性ミクロスフェアのグローバル主要企業には、Terumo、Balton、Boston Scientific、Cook Medical、Merit Medical、Varian Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

薬物溶出性ミクロスフェア市場は、種類と用途によって区分されます。世界の薬物溶出性ミクロスフェア市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
容量2ml、容量4ml、その他

【用途別セグメント】
腫瘍、血管塞栓症、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 薬物溶出性ミクロスフェア製品概要
- 種類別市場（容量2ml、容量4ml、その他）
- 用途別市場（腫瘍、血管塞栓症、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の薬物溶出性ミクロスフェア販売量予測2017-2028
- 世界の薬物溶出性ミクロスフェア売上予測2017-2028
- 薬物溶出性ミクロスフェアの地域別販売量
- 薬物溶出性ミクロスフェアの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別薬物溶出性ミクロスフェア販売量
- 主要メーカー別薬物溶出性ミクロスフェア売上
- 主要メーカー別薬物溶出性ミクロスフェア価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（容量2ml、容量4ml、その他）
- 薬物溶出性ミクロスフェアの種類別販売量
- 薬物溶出性ミクロスフェアの種類別売上
- 薬物溶出性ミクロスフェアの種類別価格
・用途別市場規模（腫瘍、血管塞栓症、その他）
- 薬物溶出性ミクロスフェアの用途別販売量
- 薬物溶出性ミクロスフェアの用途別売上
- 薬物溶出性ミクロスフェアの用途別価格
・北米市場
- 北米の薬物溶出性ミクロスフェア市場規模（種類別、用途別）
- 主要国別の薬物溶出性ミクロスフェア市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの薬物溶出性ミクロスフェア市場規模（種類別、用途別）
- 主要国別の薬物溶出性ミクロスフェア市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の薬物溶出性ミクロスフェア市場規模（種類別、用途別）
- 主要国別の薬物溶出性ミクロスフェア市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の薬物溶出性ミクロスフェア市場規模（種類別、用途別）
- 主要国別の薬物溶出性ミクロスフェア市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの薬物溶出性ミクロスフェア市場規模（種類別、用途別）
- 主要国別の薬物溶出性ミクロスフェア市場規模（トルコ、サウジアラビア）
・企業情報
Terumo、Balton、Boston Scientific、Cook Medical、Merit Medical、Varian Medical
・産業チェーン及び販売チャネル分析
- 薬物溶出性ミクロスフェアの産業チェーン分析
- 薬物溶出性ミクロスフェアの原材料
- 薬物溶出性ミクロスフェアの生産プロセス
- 薬物溶出性ミクロスフェアの販売及びマーケティング
- 薬物溶出性ミクロスフェアの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 薬物溶出性ミクロスフェアの産業動向
- 薬物溶出性ミクロスフェアのマーケットドライバー
- 薬物溶出性ミクロスフェアの課題
- 薬物溶出性ミクロスフェアの阻害要因
・主な調査結果

Drug Elutable Microspheres absorb drugs into their matrix, which can be loaded with chemotherapeutic agents.
Market Analysis and Insights: Global Drug Elutable Microspheres Market
Due to the COVID-19 pandemic, the global Drug Elutable Microspheres market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Volume 2ml accounting for % of the Drug Elutable Microspheres global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Drug Elutable Microspheres market size is valued at US$ million in 2021, while the US and Europe Drug Elutable Microspheres are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Drug Elutable Microspheres landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Drug Elutable Microspheres include Terumo, Balton, Boston Scientific, Cook Medical, Merit Medical and Varian Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Drug Elutable Microspheres Scope and Segment
Drug Elutable Microspheres market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug Elutable Microspheres market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Volume 2ml
Volume 4ml
Others
Segment by Application
Oncology
Vascular Embolism
Others
By Company
Terumo
Balton
Boston Scientific
Cook Medical
Merit Medical
Varian Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Drug Elutable Microspheres Product Introduction
1.2 Market by Type
1.2.1 Global Drug Elutable Microspheres Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Volume 2ml
1.2.3 Volume 4ml
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drug Elutable Microspheres Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Vascular Embolism
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Elutable Microspheres Sales Estimates and Forecasts 2017-2028
2.2 Global Drug Elutable Microspheres Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug Elutable Microspheres Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug Elutable Microspheres Sales by Region
2.4.1 Global Drug Elutable Microspheres Sales by Region (2017-2022)
2.4.2 Global Sales Drug Elutable Microspheres by Region (2023-2028)
2.5 Global Drug Elutable Microspheres Revenue by Region
2.5.1 Global Drug Elutable Microspheres Revenue by Region (2017-2022)
2.5.2 Global Drug Elutable Microspheres Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Elutable Microspheres Sales by Manufacturers
3.1.1 Global Top Drug Elutable Microspheres Manufacturers by Sales (2017-2022)
3.1.2 Global Drug Elutable Microspheres Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Elutable Microspheres in 2021
3.2 Global Drug Elutable Microspheres Revenue by Manufacturers
3.2.1 Global Drug Elutable Microspheres Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug Elutable Microspheres Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug Elutable Microspheres Revenue in 2021
3.3 Global Drug Elutable Microspheres Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Elutable Microspheres Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Elutable Microspheres Sales by Type
4.1.1 Global Drug Elutable Microspheres Historical Sales by Type (2017-2022)
4.1.2 Global Drug Elutable Microspheres Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
4.2 Global Drug Elutable Microspheres Revenue by Type
4.2.1 Global Drug Elutable Microspheres Historical Revenue by Type (2017-2022)
4.2.2 Global Drug Elutable Microspheres Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
4.3 Global Drug Elutable Microspheres Price by Type
4.3.1 Global Drug Elutable Microspheres Price by Type (2017-2022)
4.3.2 Global Drug Elutable Microspheres Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug Elutable Microspheres Sales by Application
5.1.1 Global Drug Elutable Microspheres Historical Sales by Application (2017-2022)
5.1.2 Global Drug Elutable Microspheres Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
5.2 Global Drug Elutable Microspheres Revenue by Application
5.2.1 Global Drug Elutable Microspheres Historical Revenue by Application (2017-2022)
5.2.2 Global Drug Elutable Microspheres Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
5.3 Global Drug Elutable Microspheres Price by Application
5.3.1 Global Drug Elutable Microspheres Price by Application (2017-2022)
5.3.2 Global Drug Elutable Microspheres Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Elutable Microspheres Market Size by Type
6.1.1 North America Drug Elutable Microspheres Sales by Type (2017-2028)
6.1.2 North America Drug Elutable Microspheres Revenue by Type (2017-2028)
6.2 North America Drug Elutable Microspheres Market Size by Application
6.2.1 North America Drug Elutable Microspheres Sales by Application (2017-2028)
6.2.2 North America Drug Elutable Microspheres Revenue by Application (2017-2028)
6.3 North America Drug Elutable Microspheres Market Size by Country
6.3.1 North America Drug Elutable Microspheres Sales by Country (2017-2028)
6.3.2 North America Drug Elutable Microspheres Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug Elutable Microspheres Market Size by Type
7.1.1 Europe Drug Elutable Microspheres Sales by Type (2017-2028)
7.1.2 Europe Drug Elutable Microspheres Revenue by Type (2017-2028)
7.2 Europe Drug Elutable Microspheres Market Size by Application
7.2.1 Europe Drug Elutable Microspheres Sales by Application (2017-2028)
7.2.2 Europe Drug Elutable Microspheres Revenue by Application (2017-2028)
7.3 Europe Drug Elutable Microspheres Market Size by Country
7.3.1 Europe Drug Elutable Microspheres Sales by Country (2017-2028)
7.3.2 Europe Drug Elutable Microspheres Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Elutable Microspheres Market Size by Type
8.1.1 Asia Pacific Drug Elutable Microspheres Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug Elutable Microspheres Revenue by Type (2017-2028)
8.2 Asia Pacific Drug Elutable Microspheres Market Size by Application
8.2.1 Asia Pacific Drug Elutable Microspheres Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug Elutable Microspheres Revenue by Application (2017-2028)
8.3 Asia Pacific Drug Elutable Microspheres Market Size by Region
8.3.1 Asia Pacific Drug Elutable Microspheres Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug Elutable Microspheres Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug Elutable Microspheres Market Size by Type
9.1.1 Latin America Drug Elutable Microspheres Sales by Type (2017-2028)
9.1.2 Latin America Drug Elutable Microspheres Revenue by Type (2017-2028)
9.2 Latin America Drug Elutable Microspheres Market Size by Application
9.2.1 Latin America Drug Elutable Microspheres Sales by Application (2017-2028)
9.2.2 Latin America Drug Elutable Microspheres Revenue by Application (2017-2028)
9.3 Latin America Drug Elutable Microspheres Market Size by Country
9.3.1 Latin America Drug Elutable Microspheres Sales by Country (2017-2028)
9.3.2 Latin America Drug Elutable Microspheres Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug Elutable Microspheres Market Size by Type
10.1.1 Middle East and Africa Drug Elutable Microspheres Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug Elutable Microspheres Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug Elutable Microspheres Market Size by Application
10.2.1 Middle East and Africa Drug Elutable Microspheres Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug Elutable Microspheres Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug Elutable Microspheres Market Size by Country
10.3.1 Middle East and Africa Drug Elutable Microspheres Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug Elutable Microspheres Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Terumo
11.1.1 Terumo Corporation Information
11.1.2 Terumo Overview
11.1.3 Terumo Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Terumo Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Terumo Recent Developments
11.2 Balton
11.2.1 Balton Corporation Information
11.2.2 Balton Overview
11.2.3 Balton Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Balton Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Balton Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Corporation Information
11.3.2 Boston Scientific Overview
11.3.3 Boston Scientific Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boston Scientific Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boston Scientific Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Corporation Information
11.4.2 Cook Medical Overview
11.4.3 Cook Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cook Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cook Medical Recent Developments
11.5 Merit Medical
11.5.1 Merit Medical Corporation Information
11.5.2 Merit Medical Overview
11.5.3 Merit Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merit Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merit Medical Recent Developments
11.6 Varian Medical
11.6.1 Varian Medical Corporation Information
11.6.2 Varian Medical Overview
11.6.3 Varian Medical Drug Elutable Microspheres Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Varian Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Varian Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug Elutable Microspheres Industry Chain Analysis
12.2 Drug Elutable Microspheres Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Elutable Microspheres Production Mode & Process
12.4 Drug Elutable Microspheres Sales and Marketing
12.4.1 Drug Elutable Microspheres Sales Channels
12.4.2 Drug Elutable Microspheres Distributors
12.5 Drug Elutable Microspheres Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Elutable Microspheres Industry Trends
13.2 Drug Elutable Microspheres Market Drivers
13.3 Drug Elutable Microspheres Market Challenges
13.4 Drug Elutable Microspheres Market Restraints
14 Key Findings in The Global Drug Elutable Microspheres Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Drug Elutable Microspheres Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Volume 2ml
Table 3. Major Manufacturers of Volume 4ml
Table 4. Major Manufacturers of Others
Table 5. Global Drug Elutable Microspheres Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Drug Elutable Microspheres Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 8. Global Drug Elutable Microspheres Sales Market Share by Region (2017-2022)
Table 9. Global Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 10. Global Drug Elutable Microspheres Sales Market Share by Region (2023-2028)
Table 11. Global Drug Elutable Microspheres Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Drug Elutable Microspheres Revenue Market Share by Region (2017-2022)
Table 13. Global Drug Elutable Microspheres Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Drug Elutable Microspheres Revenue Market Share by Region (2023-2028)
Table 15. Global Drug Elutable Microspheres Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Drug Elutable Microspheres Sales Share by Manufacturers (2017-2022)
Table 17. Global Drug Elutable Microspheres Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Drug Elutable Microspheres Revenue Share by Manufacturers (2017-2022)
Table 19. Drug Elutable Microspheres Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Drug Elutable Microspheres Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Drug Elutable Microspheres by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Elutable Microspheres as of 2021)
Table 22. Drug Elutable Microspheres Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drug Elutable Microspheres Product Offered
Table 24. Date of Manufacturers Enter into Drug Elutable Microspheres Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 27. Global Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 28. Global Drug Elutable Microspheres Sales Share by Type (2017-2022)
Table 29. Global Drug Elutable Microspheres Sales Share by Type (2023-2028)
Table 30. Global Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Drug Elutable Microspheres Revenue Share by Type (2017-2022)
Table 33. Global Drug Elutable Microspheres Revenue Share by Type (2023-2028)
Table 34. Drug Elutable Microspheres Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Drug Elutable Microspheres Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 37. Global Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 38. Global Drug Elutable Microspheres Sales Share by Application (2017-2022)
Table 39. Global Drug Elutable Microspheres Sales Share by Application (2023-2028)
Table 40. Global Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Drug Elutable Microspheres Revenue Share by Application (2017-2022)
Table 43. Global Drug Elutable Microspheres Revenue Share by Application (2023-2028)
Table 44. Drug Elutable Microspheres Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Drug Elutable Microspheres Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 47. North America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 48. North America Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 51. North America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 52. North America Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 55. North America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 56. North America Drug Elutable Microspheres Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Drug Elutable Microspheres Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 59. Europe Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 60. Europe Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 63. Europe Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 64. Europe Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 67. Europe Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 68. Europe Drug Elutable Microspheres Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Drug Elutable Microspheres Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Drug Elutable Microspheres Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Drug Elutable Microspheres Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Drug Elutable Microspheres Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Drug Elutable Microspheres Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Drug Elutable Microspheres Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Drug Elutable Microspheres Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Drug Elutable Microspheres Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Drug Elutable Microspheres Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Drug Elutable Microspheres Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Drug Elutable Microspheres Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Drug Elutable Microspheres Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Drug Elutable Microspheres Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Drug Elutable Microspheres Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Drug Elutable Microspheres Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Drug Elutable Microspheres Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Drug Elutable Microspheres Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Drug Elutable Microspheres Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Drug Elutable Microspheres Revenue by Country (2023-2028) & (US$ Million)
Table 106. Terumo Corporation Information
Table 107. Terumo Description and Major Businesses
Table 108. Terumo Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Terumo Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Terumo Recent Developments
Table 111. Balton Corporation Information
Table 112. Balton Description and Major Businesses
Table 113. Balton Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Balton Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Balton Recent Developments
Table 116. Boston Scientific Corporation Information
Table 117. Boston Scientific Description and Major Businesses
Table 118. Boston Scientific Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Boston Scientific Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Boston Scientific Recent Developments
Table 121. Cook Medical Corporation Information
Table 122. Cook Medical Description and Major Businesses
Table 123. Cook Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Cook Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Cook Medical Recent Developments
Table 126. Merit Medical Corporation Information
Table 127. Merit Medical Description and Major Businesses
Table 128. Merit Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Merit Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Merit Medical Recent Developments
Table 131. Varian Medical Corporation Information
Table 132. Varian Medical Description and Major Businesses
Table 133. Varian Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Varian Medical Drug Elutable Microspheres Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Varian Medical Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Drug Elutable Microspheres Distributors List
Table 139. Drug Elutable Microspheres Customers List
Table 140. Drug Elutable Microspheres Market Trends
Table 141. Drug Elutable Microspheres Market Drivers
Table 142. Drug Elutable Microspheres Market Challenges
Table 143. Drug Elutable Microspheres Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Elutable Microspheres Product Picture
Figure 3. Global Drug Elutable Microspheres Market Share by Type in 2021 & 2028
Figure 3. Volume 2ml Product Picture
Figure 4. Volume 4ml Product Picture
Figure 5. Others Product Picture
Figure 6. Global Drug Elutable Microspheres Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Vascular Embolism
Figure 9. Others
Figure 10. Drug Elutable Microspheres Report Years Considered
Figure 11. Global Drug Elutable Microspheres Sales 2017-2028 (K Units)
Figure 12. Global Drug Elutable Microspheres Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Drug Elutable Microspheres Revenue 2017-2028 (US$ Million)
Figure 14. Global Drug Elutable Microspheres Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Drug Elutable Microspheres Sales Market Share by Region (2017-2022)
Figure 16. Global Drug Elutable Microspheres Sales Market Share by Region (2023-2028)
Figure 17. North America Drug Elutable Microspheres Sales YoY (2017-2028) & (K Units)
Figure 18. North America Drug Elutable Microspheres Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Drug Elutable Microspheres Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Drug Elutable Microspheres Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Drug Elutable Microspheres Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Drug Elutable Microspheres Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Drug Elutable Microspheres Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Drug Elutable Microspheres Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Drug Elutable Microspheres Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Drug Elutable Microspheres Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Drug Elutable Microspheres Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Drug Elutable Microspheres in the World: Market Share by Drug Elutable Microspheres Revenue in 2021
Figure 29. Global Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 31. Global Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 32. Global Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 33. Global Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 34. North America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 35. North America Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 36. North America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 37. North America Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 38. North America Drug Elutable Microspheres Sales Share by Country (2017-2028)
Figure 39. North America Drug Elutable Microspheres Revenue Share by Country (2017-2028)
Figure 40. United States Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 43. Europe Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 44. Europe Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 45. Europe Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 46. Europe Drug Elutable Microspheres Sales Share by Country (2017-2028)
Figure 47. Europe Drug Elutable Microspheres Revenue Share by Country (2017-2028)
Figure 48. Germany Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 49. France Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Drug Elutable Microspheres Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Drug Elutable Microspheres Revenue Share by Region (2017-2028)
Figure 59. China Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 62. India Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 69. Latin America Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 71. Latin America Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Drug Elutable Microspheres Sales Share by Country (2017-2028)
Figure 73. Latin America Drug Elutable Microspheres Revenue Share by Country (2017-2028)
Figure 74. Mexico Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Drug Elutable Microspheres Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Drug Elutable Microspheres Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Drug Elutable Microspheres Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Drug Elutable Microspheres Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Drug Elutable Microspheres Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Drug Elutable Microspheres Revenue Share by Country (2017-2028)
Figure 83. Turkey Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Drug Elutable Microspheres Revenue (2017-2028) & (US$ Million)
Figure 86. Drug Elutable Microspheres Value Chain
Figure 87. Drug Elutable Microspheres Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の薬物溶出性ミクロスフェア市場インサイト及び予測（容量2ml、容量4ml、その他）(Global Drug Elutable Microspheres Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の薬物溶出性ミクロスフェア市場インサイト及び予測（容量2ml、容量4ml、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp